Dimitri Grigoriadis
Chief Tech/Sci/R&D Officer bei NEUROCRINE BIOSCIENCES, INC.
Profil
Dimitri E. Grigoriadis ist Chief Research Officer bei Neurocrine Biosciences, Inc. und Mitglied der International Society of Psychoneuroendocrinology. In der Vergangenheit war er Senior Scientist-Neuroscience Group bei DuPont Pharmaceuticals Co. Er erhielt einen Undergraduate-Abschluss von der University of Guelph und einen Graduate-Abschluss sowie einen Doktortitel von der University of Toronto.
Aktive Positionen von Dimitri Grigoriadis
Unternehmen | Position | Beginn |
---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01.01.2013 |
International Society of Psychoneuroendocrinology | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Dimitri Grigoriadis
Unternehmen | Position | Ende |
---|---|---|
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Corporate Officer/Principal | 01.01.1993 |
Ausbildung von Dimitri Grigoriadis
University of Guelph | Undergraduate Degree |
University of Toronto | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Health Technology |
International Society of Psychoneuroendocrinology |